Transcriptomics

Dataset Information

0

Gene Expression Profile of Radiation Therapy Resistant BRAFV600E Pediatric Gliomas


ABSTRACT: Inhibitors of the MAPK pathway (MAPKi) have shown significant activity in treatment of childhood BRAF-activated brain tumors. However, for tumors harboring BRAFV600E mutations, the drugs are rarely curative, and patients can become refractory to treatment. Combining MAPKi with low dose X-ray therapy (XRT) has the potential to improve the cure rate, but development of XRT resistance poses a major challenge. To understand the mechanisms of radiation resistance in BRAFV600E type pediatric low-grade gliomas, radiation resistance models were developed by using BT-40 pediatric low-grade glioma (PLGG) PDX model harboring BRAFV600E mutation. RNA sequencing was performed to determine the gene expression profile of primary tumors and resistant tumors. Each tumor tissue was transplanted to 3 scid mice respectively. When tumor volume reach ~0.3~0.6 cm3, tumor tissue (from three mice, triplicates) were collected and were snap-frozen in liquid nitrogen. RNA was isolated and applied to subsequent 100bp paired read sequencing run with Illumina NovaSeq 6000 platform at 100 bp paired-end module.

ORGANISM(S): Homo sapiens

PROVIDER: GSE271064 | GEO | 2025/09/17

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2025-09-17 | GSE284577 | GEO
2023-06-27 | GSE222850 | GEO
2022-07-12 | GSE156619 | GEO
2024-12-05 | GSE270891 | GEO
2011-09-07 | E-MEXP-2909 | biostudies-arrayexpress
2011-09-07 | E-MEXP-2910 | biostudies-arrayexpress
2021-06-06 | GSE115444 | GEO
2019-07-01 | GSE126881 | GEO
2015-08-25 | E-GEOD-72269 | biostudies-arrayexpress
2022-08-24 | GSE174624 | GEO